Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of once-daily metformin XR in type 2 diabetes with CKD stages 1–3
2016-001233-27Phase 2Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by CHU Amiens-Picardie. Primary endpoint: 24-hour blood glucose control at 2 weeks. Started Nov 2016; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-001233-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001233-27.